Hewson, Visco, FDA discussed on Dentistry Uncensored with Howard Farran


We found the case of 'em are is we developed a site specific MRI scanner which is as small as a dental stool, and that that site specific scanner allows for very very inexpensive MRI's where were a patient could have an MRI the MRI could be in the corner of. Doctor's office off the pitas office. And so it could it's it was for a lamb if it was for a knee. If it was for a wrist. Then those applications can be readily done right there in the doctor's office and done very very inexpensively that MRI scanner we brought to market then in addition to that we also developed a. A treatment for surgical adhesions or actually put the prevention of surgical Asians, particularly for cardiac adhesions, because there's always been a problem when someone goes in for cardiac surgery, and that that cardiac surgeon will tell you if you wanna see which was an operation as compared to reoperate even just look on the ceiling of the surgical, suite. And if it's covered with blood, then you know, that it was the reauthorization because in order to be able to get to the heart. Then they have to tease the way all the surgical adhesions that had formed from that I operated so within those surgical adhesions blood vessels auto reason arterials also fall, and it's so it means Eddie additional risk for the patients of several hours more on the table as four and. Also, the additional sweet time and surgeons time so in its stead, we had developed a bio polymer, which can be it looks much like select Saran wrap, but it's buyer resolvable and can be tacked to the inside of the chest wall, and it helps to prevent surgical Hewson's from forming between the heart the pericardium of the heart and the and the chess will so these said he's in form within the first two weeks following surgery. So if the the bio Pala resorts after a few weeks, so in that interim period did that the Haege is prevented from forming between the chest wall and the heart. And so that when a patient goes in for reauthorization, then the surgeon don't have to deal with the with additional operative. Time and additional risk to the patient. So that product was approved in Europe, and it was also approved in the United States. So so that's an additional product also developed products for scar remediation based on a silicone padding silicone gel and those were brought to market and done also developed a device called the sure closure device, which which is a one time used disposable device which which helps to convert tissue deficit wounds that are non sutra Bill de so lot because of the deficit of tissue in there, perhaps it's because of a traumatic wound or because it's a cancer surgery where a good deal of tissue is being removed with the borders of the wound so far apart that it cannot be suture. So we requires a fill in with granulation. Tissue or requires a graft in its stead, these massive wounds were able to be closed with this device which actually using a tension over a period of twenty minutes or so against the borders of the wound allowed these collagen fire fibers which randomly aligned in the skin. And this is what's known as the Visco elastic properties of skin. So these randomly aligned colleges of fibers with tension control attention line up and slide past each other. So you get an enormous amount of stretch. And so that these wounds can be suture so used to require a two week stay in the hospital with grafting and the creation of a a secondary wound to for the harvest site of the graft. No longer is necessary in many cases with the use of this device. Ice because that same wound canal be suited and twenty minutes, or so mazing device and fact we I saw this device it was being used in Israel at because of traumatic ones. And so one soldier where shrapnel had blown through his leg. And the wind was as lodges grapefruit, and that one was closed with this particular prototype at this particular device. So that was a product that we got onto the market FDA approved..

Coming up next